在第三级护理中心进行抗癌药物治疗后的皮肤反应
Deeptara Pathak Thapa1, Sudip Shrestha2, Saloni Shrestha3
1Department of Dermatology, Nepal Medical College and Teaching Hospital, Jorpati, Kathmandu, Nepal.
JNMA; journal of the Nepal Medical Association
|February 27, 2024
概括
在癌症患者中,与抗癌药物相关的皮肤副作用的患病率为2.22%. 原流水和手掌 - 脚掌红色消化症是观察到的最常见的化疗药物副作用.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮肤反应是抗癌药物治疗的常见皮肤学副作用.
- 这些反应可以显著影响患者的生活质量,从轻度到严重.
- 了解这些反应的患病率对于患者管理至关重要.
研究的目的:
- 确定接受抗癌药物治疗的癌症患者皮肤反应的流行率.
- 为了确定与化疗相关的最常见的皮肤反应类型.
- 提供来自第三级护理中心环境的数据.
主要方法:
- 进行了一项描述性的横截面研究.
- 从皮肤病门诊部的癌症患者收集数据.
- 研究期间为2021年10月至2022年12月,采用方便抽样.
主要成果:
- 皮肤反应的患病率为2.22% (3288名患者中73名).
- 受影响患者的平均年龄为49.42岁.
- 最常见的反应是动脉流水 (30.10%) 和手掌 - 脚掌红色化解 (19.94%).
结论:
- 观察到的皮肤反应的发病率低于类似研究中的情况.
- 建议采用跨学科的方法来管理这些化疗副作用.
- 早期识别和治疗调整是改善患者结果的关键.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
07:08Establishment of a Robust and Reproducible Model of Radiation-Induced Skin and Muscle Fibrosis
Published on: August 31, 2022
1.6K
相关概念视频
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Allergic Drug Reactions
842
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
842
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
